2025 Brings Real-World Use of Clinical Biomarkers in Updated Multiple Sclerosis Diagnostic Criteria

The latest diagnostic criteria for multiple sclerosis (MS) were initially presented at the 2024 European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress and were finalized in late September 2025 in The Lancet Neurology.1-3 Throughout this year, clinicians have had the opportunity to incorporate the updated criteria into their clinical practice to support the care of patients with MS.